Skip to main navigation Skip to search Skip to main content

IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8 + T cells

  • Qianting Yang
  • , Gang Li
  • , Yibei Zhu
  • , Lin Liu
  • , Elizabeth Chen
  • , Heth Turnquist
  • , Xueguang Zhang
  • , Olivera J. Finn
  • , Xinchun Chen
  • , Binfeng Lu
  • University of Pittsburgh
  • Southern University of Science and Technology
  • Soochow University

Research output: Contribution to journal › Article › peer-review

181 Scopus citations

Abstract

The effector functions of CD8 + T cells are influenced by tissue inflammatory microenvironments. IL-33, a member of the IL-1 family, acts as a danger signal after its release during cell necrosis. The IL-33/ST2 axis has been implicated in various Th2 responses. Its role in CD8 + T-cell-mediated immune response is, however, not known. Here we find that type 1 cytotoxic T (Tc1) cells cultured in vitro unexpectedly express high levels of the IL-33 receptor ST2. Interestingly, the expression of ST2 in Tc1 cells is dependent on T-bet, a master Th1/Tc1 transcription factor. In addition, IL-33 enhances TCR-triggered IFN-γ production. IL-33 together with IL-12 can stimulate IFN-γ production in Tc1 cells. Moreover, IL-33 synergizes with IL-12 to promote CD8 + T-cell effector function. The synergistic effect of IL-33 and IL-12 is partly mediated by Gadd45b. Together, these in vitro data establish a novel role of IL-33 in promoting effector type 1 adaptive immune responses.

Original languageEnglish
Pages (from-to)3351-3360
Number of pages10
JournalEuropean Journal of Immunology
Volume41
Issue number11
DOIs
StatePublished - Nov 2011

Keywords

  • CD8 T cells
  • Cellular activation
  • Cytokines
  • Signal transduction

Fingerprint

Dive into the research topics of 'IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8 + T cells'. Together they form a unique fingerprint.

Cite this